GDTC
Price
$0.83
Change
-$0.02 (-2.35%)
Updated
Feb 4, 01:48 PM (EDT)
Capitalization
9.97M
89 days until earnings call
Intraday BUY SELL Signals
KAPA
Price
$0.65
Change
-$0.01 (-1.52%)
Updated
Feb 4, 02:21 PM (EDT)
Capitalization
13.74M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GDTC vs KAPA

Header iconGDTC vs KAPA Comparison
Open Charts GDTC vs KAPABanner chart's image
CytoMed Therapeutics
Price$0.83
Change-$0.02 (-2.35%)
Volume$200
Capitalization9.97M
Kairos Pharma
Price$0.65
Change-$0.01 (-1.52%)
Volume$1.16K
Capitalization13.74M
GDTC vs KAPA Comparison Chart in %
GDTC
Daily Signal:
Gain/Loss:
KAPA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GDTC vs. KAPA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a Hold and KAPA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GDTC: $0.85 vs. KAPA: $0.66)
Brand notoriety: GDTC and KAPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 11% vs. KAPA: 69%
Market capitalization -- GDTC: $9.97M vs. KAPA: $13.74M
GDTC [@Biotechnology] is valued at $9.97M. KAPA’s [@Biotechnology] market capitalization is $13.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 1 FA rating(s) are green whileKAPA’s FA Score has 1 green FA rating(s).

  • GDTC’s FA Score: 1 green, 4 red.
  • KAPA’s FA Score: 1 green, 4 red.
According to our system of comparison, both GDTC and KAPA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GDTC’s TA Score shows that 5 TA indicator(s) are bullish while KAPA’s TA Score has 2 bullish TA indicator(s).

  • GDTC’s TA Score: 5 bullish, 2 bearish.
  • KAPA’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, GDTC is a better buy in the short-term than KAPA.

Price Growth

GDTC (@Biotechnology) experienced а +1.71% price change this week, while KAPA (@Biotechnology) price change was -7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

GDTC is expected to report earnings on May 04, 2026.

KAPA is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KAPA($13.7M) has a higher market cap than GDTC($9.97M). KAPA YTD gains are higher at: -7.042 vs. GDTC (-36.330).
GDTCKAPAGDTC / KAPA
Capitalization9.97M13.7M73%
EBITDAN/A-4.9M-
Gain YTD-36.330-7.042516%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A5.58M-
Total DebtN/A142K-
TECHNICAL ANALYSIS
Technical Analysis
GDTCKAPA
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
87%
Bullish Trend 21 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GDTC
Daily Signal:
Gain/Loss:
KAPA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANIK10.020.39
+4.05%
Anika Therapeutics
ATO168.812.29
+1.38%
Atmos Energy Corp
CATY52.47-0.10
-0.19%
Cathay General Bancorp
GYRE7.92-0.29
-3.53%
Gyre Therapeutics
CXAI0.26-0.02
-5.58%
CXApp

GDTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with CYCN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-1.16%
CYCN - GDTC
35%
Loosely correlated
-10.14%
CVKD - GDTC
29%
Poorly correlated
-7.04%
QSI - GDTC
28%
Poorly correlated
-0.91%
ADIL - GDTC
27%
Poorly correlated
-1.58%
JSPR - GDTC
27%
Poorly correlated
-2.04%
More

KAPA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KAPA has been loosely correlated with AZTR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KAPA jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAPA
1D Price
Change %
KAPA100%
-1.12%
AZTR - KAPA
39%
Loosely correlated
-4.62%
GDTC - KAPA
26%
Poorly correlated
-1.16%
KLTO - KAPA
25%
Poorly correlated
-2.86%
PHIO - KAPA
24%
Poorly correlated
-0.86%
BGMS - KAPA
23%
Poorly correlated
-7.96%
More